Global Preventable Vaccines Market 2015-2019
About Preventable Vaccines
Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.
TechNavio's analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Preventable Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable. The report does not cover emerging vaccines for diseases that are not currently vaccine preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer's disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson's disease, or West Nile virus infection.The report has broadly categorized preventable vaccines into two major segments:
TechNavio Announces the Publication of its Research Report – Global Preventable Vaccines Market 2015-2019
TechNavio recognizes the following companies as the key players in the Global Preventable Vaccines Market: GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Pfizer Inc. and Sanofi SA
Other Prominent Vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals, bioCSL, Bio Med, Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novartis, Nuron, Panacea Biotec, Protein Sciences, Roche, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, S K Chemicals, Takeda Pharmaceutical, Valeant Pharmaceuticals and Zydus Cadila.
Commenting on the report, an analyst from TechNavio’s team said: “One major trend emerging in the market is the strategic alliances of the vendors in the market, resulting in consolidation. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Large pharmaceutical companies are focused on consolidating their position in the Global Preventable Vaccines market.”
According to the report, the primary driving factor is the inclusion of pediatric vaccines in the national immunization schedule of many countries. This helps increase the consumption of vaccines in the market, thereby boosting growth.
Further, the report states that the inadequate vaccine coverage in the world is a major challenge to the growth of the market. Lack of awareness and negligence among individuals, besides the subsidies offered by governments for a particular age group, are the most prominent factors that decrease these coverage rates.
GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi , Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals , bioCSL, Bio Med , Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals,Kaketsuken, LG Life Sciences, Mitsubishi Tanabe Pharma, Lupin, Nuron , Protein Sciences, Panacea Biotec, Roche, Serum Institute of India , Shenzhen Kangtai Biological Products , Serum Institute of India, Sinovac Biotech, S K Chemicals,Takeda Pharmaceutical , Valeant Pharmaceuticals, Zydus Cadila
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook